Results 351 to 360 of about 3,376,621 (386)

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Supportive Care in Cancer, 2016
K. Jordan, A. Chan, R. Gralla, Franziska Jahn, B. Rapoport, D. Warr, P. Hesketh   +6 more
semanticscholar   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Novel antineoplastic agents

Current Oncology Reports, 2000
openaire   +3 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Recent progress in the treatment of cancer in children

Ca-A Cancer Journal for Clinicians, 2021
Theodore W Laetsch
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Statins as an antineoplastic agent

QJM: An International Journal of Medicine
H A A Raja, A Zulfiqar, A A Abbasi, H Arshad, P Nain, V Jaiswal, J Mattumpuram   +6 more
openaire   +2 more sources

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back

Ca-A Cancer Journal for Clinicians, 2014
Giada Bianchi
exaly